Introduction
Several studies have demonstrated an association between insulin resistance (IR) or hyperinsulinaemia and essential hypertension. 1, 2 However, the effect of obesity in in¯uencing this relationship has been contradictory with some groups ®nding greater insulin resistance 3, 4 and others reporting no signi®cant changes 5 between obese hypertensive subjects and obese normotensive subjects. Secondly, there is uncertainty as to whether the relationship between IR and hypertension is applicable to all populations. Saad et al 6 have shown a causal relationship in the white US population, but not in Pima Indians or blacks. Similarly, no correlation has been found in South African blacks 7 and Mauritians. 8 Asian Indian subjects are ethnically different from other populations and are reported to have high incidences of diabetes and coronary heart disease (CHD). 9 We had previously shown 10 the presence of IR in nonobese hypertensive subjects, belonging to the Asian Indian community, living in the city of Mumbai, Western India. Subsequently, we had reported that among the nonobese hypertensive subjects, only those subjects with hyperinsulinaemia had abnormal electrocardiographic changes.
11
Asian Indian subjects are generally lean and the prevalence of obesity is not higher than in other populations. However, incidence of obesity among hypertensive subjects is similar to other populations. Since obesity has been strongly associated with hypertension and IR independently, 12 we suspected a pathogenetic role of obesity, in aggravating the already existing IR in hypertension. The present study was carried out to determine whether the combination of obesity and hypertension has an additive effect on IR compared to either of them alone.
Methods

Subjects
A total of 56 subjects, 28 hypertensive (15 obese and 13 nonobese) and 28 normotensive (15 obese and 13 nonobese) subjects were recruited from the Municipal Corporation of Mumbai, as described previously. 10 For each subject, a detailed medical history, family history, smoking habits, diet and exercise, was recorded to rule out secondary hypertension. They were also subjected to a physical examination, which included height, weight and blood pressure. Obesity was de®ned as a body mass index (BMI) b 28 kgam 2 for men and b 25 kgam 2 for women. Subjects were considered nonobese if the BMI was`25 kgam 2 for men,`22 kgam 2 for women. Subjects with borderline BMI were excluded. All subjects had abdominal obesity and the waist-to-hip ratio (WHR) was b 0.85. The selection of normotensive and hypertensive subjects was made, as previously described. 10 The study was approved by the Scienti®c Advisory Committee.
Protocol
The subjects were given a standard oral glucose tolerance test (OGTT) of 75 g, after a 12 ± 14 h overnight fast. Serum insulin was determined by radioimmunoassay (RIA) (RIAK-1, Board of Radiation and Isotope Technology, Bombay, India). Plasma glucose (Menarini Industries, Florence, Italy), fasting serum triglycerides and cholesterol (Gilford, Ohio, USA) were determined by enzymatic methods.
Data analysis
Data are presented as mean AE s.e.m. The between group comparison of mean values was performed using the unpaired`t' test. Area under the curve (AUC), was calculated by summing the areas of successive triangles and rectangles under the graph, using the absolute values of plasma insulin.
Results
The effect of obesity on insulin resistance was studied by comparing obese subjects with nonobese subjects who are either normotensive or hypertensive. Obese normotensive subjects were well matched for age, gender and blood pressure, with the nonobese normotensive subjects (Table 1 ). Any differences in metabolic characteristics between these two groups is attributable to increased BMI. Obese hypertensive subjects are comparable with nonobese hypertensive subjects in terms of blood pressure and age.
Among the 13 nonobese hypertensive subjects, seven were on antihypertensive therapy, involving calcium channel blockers, 5 or angiotensin converting enzyme (ACE) inhibitors 1 or methyldopa. 1 They had been on medication for 2.1 AE 0.8 y (meanAE s.e.m.). Six subjects were newly diagnosed and untreated. In the obese hypertensive subjects, seven were taking calcium channel blockers, two were on ACE inhibitors and two were on methyldopa. The duration (meanAE s.e.m.) of treatment was 6.0 AE 2.1 y. Untreated subjects 4 had hypertension for less than six months. Both the groups of obese subjects exhibited lower high density lipoprotein (HDL)-cholesterol concentrations compared to nonobese subjects, but this was not statistically signi®cant. Fasting serum triglycerides of obese hypertensive subjects showed a tendency towards elevated concentrations, but the difference did not reach statistical signi®cance.
The plasma glucose response (Table 2 ) of all four groups of subjects during OGTT showed normal glucose tolerance. Fasting serum insulin concentrations of obese subjects, both in the presence and absence of hypertension, were 3 ± 4 times higher (P`0.02) than the nonobese subjects. Following the glucose load, although both groups of obese subjects exhibited higher insulin responses, a statistically signi®cant elevation was clearly demonstrable only in the normotensive group. A 60% greater serum insulin concentration was observed at 1.0 h from OGTT in the obese normotensive subjects compared to the non-obese. This resulted in the 65% increase (P`0.01) in the AUC insulin of the obese normotensive subjects ( Table 2) . Homeostatic model assessment, insulin resistance (HOMA I), calculated on the basis of fasting insulin and glucose concentration, was signi®cantly higher in both the groups of obese subjects studied (Table 2) . *P`0.02; **P`0.01 vs nonobese normotensive subjects ***P`0.05; ****P`0.01 vs nonobese hypertensive subjects. IR insulin resistance; HOMA ; AUC area under the curve. Insulin resistance in obese hypertension AR Marita et al
Discussion
The present study suggests the presence of insulin resistant in obese normotensive and obese hypertensive Asian Indian subjects. The presence of IR was characterised by: 1) elevated fasting insulin concentrations and increased HOMA IR, both re¯ecting basal insulin sensitivity, 13, 14 , and 2) elevated insulin concentrations in to OGTT, re¯ecting glucose induced insulin sensitivity. 15 Both these indices were altered signi®cantly in the obese normotensive subjects, while in obese hypertensive subjects only basal insulin sensitivity was affected. Since obese hypertensive subjects did not exhibit greater IR compared to obese normotensive subjects, the present results rule out any direct role for hypertension in exacerbating the IR in obesity. These ®ndings are in agreement with other studies 5, 16 and differ from the reports of Istfan et al 17 who used the minimal model in the evaluation of insulin sensitivity. Bhatnagar et al 18 have reported hyperinsulinaemia in Asian Indian obese hypertensive subjects. However, postglucose insulin concentrations in that study are not different from basal levels in the controls and that could be a methodological problem, making it dif®cult to compare with our data.
We had previously demonstrated the effect of hypertension in causing hyperinsulinaemia in nonobese subjects. 10, 11 In the present study, we determined the effect of obesity in normotensive subjects and hypertensive subjects. As a result, the nonobese hypertensive subjects chosen to match the obese group are younger compared to nonobese normotensive subjects (46.9 y vs 55.2 y, Table 1 ) and both these subjects are still younger compared to nonobese subjects in the previous studies 10, 11 (aged 58.6 ± 63.8 y). This age difference between nonobese subjects in the present study and in our previous studies could play a role in causing the different levels of hyperinsulinaemia in the present study. In the present study, hyperinsulinaemia was seen in both the basal state and in the OGTT, whereas in our previous studies on nonobese subjects, 10, 11 hyperinsulinaemia was observed only during OGTT. It is not unlikely that hypertension and obesity in¯uence postglucose insulin concentrations independently and possibly confound each other when both are present in the same individual. Unfortunately we do not have any data to con®rm this.
Conclusion
To our knowledge, there has been no other study reported in Asian Indian hypertensive subjects so far. In summary, our limited data attribute a major role for obesity in causing IR in obese hypertensive Asian subjects from Western India. Further studies using more re®ned methods, such as glucose clamp technique, are needed to fully evaluate the role of IR in this population, presently facing increased cardiovascular mortality compared to other populations.
